Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
Jump to:
Preferred Name | Levocarnitine | |
Synonyms |
|
|
Definitions |
An amino acid derivative. Levocarnitine facilitates long-chain fatty acid entry into mitochondria, delivering substrate for oxidation and subsequent energy production. Fatty acids are utilized as an energy substrate in all tissues except the brain. (NCI04) |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C26657 |
|
Accepted_Therapeutic_Use_For |
Carnitine deficiency; End-stage renal disease
|
|
ALT_DEFINITION |
A form of carnitine, which is a substance made in muscle and liver tissue and found in certain foods, such as meat, poultry, fish, and some dairy products. Carnitor is also a drug that is used to treat patients who do not make enough carnitine and is being studied as a way to prevent tissue damage caused by chemotherapy. Carnitine is a type of dietary supplement.
|
|
CAS_Registry |
541-15-1
|
|
CHEBI_ID |
CHEBI:16347
|
|
Chemical_Formula |
C7H15NO3
|
|
code |
C26657
|
|
Contributing_Source |
CTRP FDA
|
|
definition |
An amino acid derivative. Levocarnitine facilitates long-chain fatty acid entry into mitochondria, delivering substrate for oxidation and subsequent energy production. Fatty acids are utilized as an energy substrate in all tissues except the brain. (NCI04)
|
|
Display_Name |
Levocarnitine
|
|
FDA_UNII_Code |
0G389FZZ9M
|
|
Has_Salt_Form | ||
in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 http://purl.obolibrary.org/obo/NCIT_C176424 |
|
label |
Levocarnitine
|
|
Legacy Concept Name |
Levocarnitine
|
|
NCI_Drug_Dictionary_ID |
301896
|
|
PDQ_Closed_Trial_Search_ID |
301896
|
|
PDQ_Open_Trial_Search_ID |
301896
|
|
Preferred_Name |
Levocarnitine
|
|
prefixIRI |
NCIT:C26657
|
|
prefLabel |
Levocarnitine
|
|
Semantic_Type |
Pharmacologic Substance
|
|
UMLS_CUI |
C0087163
|
|
subClassOf |
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping